πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Cerus Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Engineered T Cell Therapeutics

CERo Therapeutics Holdings, Inc. is an immunotherapy company focused on developing engineered T cell therapeutics for cancer treatment, particularly targeting hematologic malignancies using innovative immune system integration strategies.

Tags: T cell therapeutics, biotechnology, cancer treatment, hematologic malignancies, immunotherapy

Symbol: CERO

Recent Price: $0.06

Industry: Biotechnology

CEO: Mr. Christopher B. Ehrlich M.B.A.

Sector: Healthcare

Employees: 8

Address: 201 Haskins Way, South San Francisco, CA 94080

Phone: 650-407-2376

Last updated: 2024-12-31

Embecta Corp.

Embecta Corp. logo
Market Cap: Medium
Employees: High

pen needles, syringes, safety devices, digital applications

Embecta Corp. is a medical device company focused on providing solutions to enhance the health and wellbeing of people living with diabetes. Its offerings include products like pen needles, syringes, safety devices, and digital applications, with a primary market of wholesalers and distributors in the US and internationally.

Tags: diabetes, digital health, healthcare, medical devices, pen needles, syringes

Symbol: EMBC

Recent Price: $20.50

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Devdatt Kurdikar

Sector: Healthcare

Employees: 2200

Address: 300 Kimball Drive, Parsippany, NJ 07054

Phone: 201 847 6880

Last updated: 2024-12-31

Glaukos Corporation

Glaukos Corporation logo
Market Cap: Highest
Employees: Medium

i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR

Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.

Tags: corneal disorders, glaucoma treatment, i Dose TR, i Stent, medical technology, ophthalmic, pharmaceutical, retinal diseases

Symbol: GKOS

Recent Price: $149.51

Industry: Medical - Devices

CEO: Mr. Thomas William Burns

Sector: Healthcare

Employees: 907

Address: 229 Avenida Fabricante, San Clemente, CA 92672

Phone: 949 367 9600

Last updated: 2024-12-31

Aethlon Medical, Inc.

Aethlon Medical, Inc. logo
Market Cap: Lowest
Employees: Lowest

Aethlon Hemopurifier

Aethlon Medical, Inc. is a medical technology company focused on developing diagnostic and therapeutic products for life and organ threatening diseases, including the Aethlon Hemopurifier device for removing tumor-derived exosomes and viruses.

Tags: COVID-19, cancer, diagnostic, exosomes, immunotherapeutic device, medical technology, therapeutic, viruses

Symbol: AEMD

Recent Price: $0.66

Industry: Medical - Devices

CEO: Mr. James B. Frakes M.B.A.

Sector: Healthcare

Employees: 14

Address: 11555 Sorrento Valley Road, San Diego, CA 92121

Phone: 619 941 0360

Leadership

  • James B. Frakes, Chief Executive Officer and Chief Financial Officer
  • Steven LaRosa, M.D., Chief Medical Officer
  • John Nguyen, Vice President of Manufacturing
  • Edward G. Broenniman, Chairman of the Board
  • Angela Rossetti,
  • Chetan S. Shah, M.D.,
  • Nicolas Gikakis, Director

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Cerus Corporation

Cerus Corporation logo
Market Cap: Low
Employees: Medium

INTERCEPT Blood System

Cerus Corporation is focused on enhancing blood safety through its INTERCEPT Blood System, a technology designed to reduce blood-borne pathogens in donated blood components for transfusion.

Tags: INTERCEPT Blood System, biomedical, blood safety, pathogen reduction, transfusion

Symbol: CERS

Recent Price: $1.55

Industry: Medical - Devices

CEO: Mr. William M. Greenman

Sector: Healthcare

Employees: 625

Address: 1220 Concord Avenue, Concord, CA 94520

Phone: 925 288 6000

Last updated: 2024-12-31

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. logo
Market Cap: High
Employees: Low

therapeutic monoclonal and bispecific antibodies

Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.

Tags: biopharmaceutical, bispecific antibodies, cancer treatment, inflammatory diseases, monoclonal antibodies

Symbol: CLDX

Recent Price: $25.12

Industry: Biotechnology

CEO: Mr. Anthony S. Marucci M.B.A.

Sector: Healthcare

Employees: 160

Address: Perryville III Building, Hampton, NJ 08827

Phone: 908 200 7500

Leadership

  • Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
  • Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
  • Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
  • Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
  • Sam Martin, Senior Vice President and Chief Financial Officer
  • Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
  • Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
  • Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
  • Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
  • Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
  • Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
  • Keith L. Brownlie, Former Partner, Ernst & Young LLP
  • Herbert J. Conrad, Former President, Roche Pharmaceuticals US
  • James J. Marino, J.D., Former Partner, Dechert LLP
  • Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
  • Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
  • Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
  • Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
  • Carl June, M.D.,
  • Michel Nussenzweig, M.D., Ph.D.,
  • Marc E. Rothenberg M.D., Ph.D.,
  • Joseph Schlessinger, Ph.D.,
  • Louis Weiner, M.D.,

Last updated: 2024-12-31

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. logo
Market Cap: Low
Employees: Lowest

CLR 131

Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.

Tags: biopharmaceutical, cancer treatment, drug development, phospholipid drug conjugate

Symbol: CLRB

Recent Price: $0.29

Industry: Biotechnology

CEO: Mr. James V. Caruso

Sector: Healthcare

Employees: 20

Address: 100 Campus Drive, Florham Park, NJ 07932

Phone: 608 441 8120

Leadership

  • James Caruso, President, CEO and Director
  • Chad Kolean, Chief Financial Officer
  • Shane Lea, Chief Commercial Officer
  • Jarrod Longcor, Chief Operating Officer
  • Andrei Shustov, Senior Vice President, Medical
  • Douglas J. Swirsky, Chairman of the Board
  • Asher Alban Chanan-Khan, MD., Director
  • Frederick W. Driscoll, Director
  • Stefan D. Loren, Ph.D., Director
  • John Neis, Director
  • Cellectar Biosciences, Inc., Company Information

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

Cytosorbents Corporation

Cytosorbents Corporation logo
Market Cap: Lowest
Employees: Low

Cyto Sorb

Cytosorbents Corporation specializes in medical devices for blood purification, focusing on treatments for sepsis and critical care. Their principal product, Cyto Sorb, is used in critical health applications and organ transplant procedures.

Tags: Blood Purification, Critical Care, Medical Devices, Organ Transplant, Sepsis Treatment

Symbol: CTSO

Recent Price: $0.90

Industry: Medical - Devices

CEO: Dr. Phillip P. Chan M.D., Ph.D.

Sector: Healthcare

Employees: 186

Address: 305 College Road East, Princeton, NJ 08540

Phone: 732 329 8885

Last updated: 2024-12-31

Cue Biopharma, Inc.

Cue Biopharma, Inc. logo
Market Cap: Low
Employees: Lowest

CUE-101

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing biologic drugs to modulate the human immune system for treating cancers, chronic infectious diseases, and autoimmune disorders.

Tags: autoimmune disorders, biopharmaceutical, cancer, chronic diseases, immune system

Symbol: CUE

Recent Price: $1.02

Industry: Biotechnology

CEO: Mr. Daniel R. Passeri J.D., M.Sc.

Sector: Healthcare

Employees: 53

Address: 21 Erie Street, Cambridge, MA 02139

Phone: 617 949 2680

Leadership

  • Dan Passeri, Chief Executive Officer
  • Anish Suri, President and Chief Scientific Officer
  • Lucinda Warren, Chief Business Officer
  • Matteo Levisetti, Chief Medical Officer
  • Kerri-Ann Millar, Chief Financial Officer
  • Colin Sandercock, Senior Vice President and General Counsel
  • Frank Morich, M.D., Ph.D., Chairman of the Board
  • Dan Passeri, M.Sc., J.D., Chief Executive Officer
  • Peter Kiener, D.Phil.,
  • Fred Driscoll,
  • Patrick Verheyen,
  • Pamela D. Garzone, Ph.D.,

Last updated: 2024-12-31

Geron Corporation

Geron Corporation logo
Market Cap: High
Employees: Low

Imetelstat

Geron Corporation is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapeutics for myeloid hematologic malignancies, notably through their telomerase inhibitor, imetelstat, which is in Phase 3 clinical trials.

Tags: biopharmaceutical, clinical trials, imetelstat, myeloid hematologic malignancies, telomerase inhibitor

Symbol: GERN

Recent Price: $3.40

Industry: Biotechnology

CEO: Dr. John A. Scarlett M.D.

Sector: Healthcare

Employees: 141

Address: 919 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 473 7700

Leadership

  • John A. Scarlett, M.D., Chairman of the Board, President and Chief Executive Officer
  • Melissa A. Kelly Behrs, Executive Vice President, Business Operations and Chief Alliance Officer
  • Faye Feller, M.D., Executive Vice President, Chief Medical Officer
  • Andrew J. Grethlein, Ph.D., Executive Vice President, Chief Operating Officer
  • Edward Koval, Executive Vice President and Chief Business Officer
  • Shannon T. Odam, Senior Vice President, Chief People Officer
  • Michelle Robertson, Executive Vice President, Chief Financial Officer and Treasurer
  • Scott A. Samuels, Esq., Executive Vice President, Chief Legal Officer and Secretary
  • Jim Ziegler, Executive Vice President, Chief Commercial Officer
  • Gaurav Aggarwal, M.D., Compensation Committee, Strategic Committee (Chair)
  • Dawn C. Bir, Nominating and Corporate Governance Committee (Chair), Compensation Committee
  • V. Bryan Lawlis, Ph.D., Audit Committee, Nominating and Corporate Governance Committee
  • John F. McDonald, Audit Committee, Strategic Committee
  • Susan M. Molineaux, Ph.D., Compensation Committee (Chair), Nominating and Corporate Governance Committee
  • Elizabeth G. O’Farrell, Lead Director, Audit Committee (Chair), Strategic Committee
  • Robert J. Spiegel, M.D., FACP, Compensation Committee, Nominating and Corporate Governance Committee

Last updated: 2024-12-31

Immuneering Corporation

Immuneering Corporation logo
Market Cap: Lowest
Employees: Low

IMM-1-104 and IMM-6-415

Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.

Tags: biopharmaceutical, cancer treatment, drug development, neuroscience, oncology

Symbol: IMRX

Recent Price: $2.25

Industry: Biotechnology

CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.

Sector: Healthcare

Employees: 66

Address: 245 Main Street, Cambridge, MA 02142

Phone: 617 500 8080

Last updated: 2024-12-31

Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Decoy20

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.

Tags: Decoy20, anti-cancer, anti-viral, biotechnology, immunotherapy

Symbol: INDP

Recent Price: $0.87

Industry: Biotechnology

CEO: Mr. Jeffrey A. Meckler

Sector: Healthcare

Employees: 7

Address: 3 Columbus Circle, New York, NY 10019

Phone: 347 480 9760

Last updated: 2024-12-31

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. logo
Market Cap: Lowest
Employees: Lowest

INTASYL therapeutic platform

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.

Tags: ACT, BRD4, Biotechnology, Cancer, Immuno-Oncology, PD-1, TIGIT, Therapeutics

Symbol: PHIO

Recent Price: $1.90

Industry: Biotechnology

CEO: Mr. Robert J. Bitterman

Sector: Healthcare

Employees: 8

Address: 257 Simarano Drive, Marlborough, MA 01752

Phone: 508 767 3861

Last updated: 2024-12-31

Xencor, Inc.

Xencor, Inc. logo
Market Cap: High
Employees: Low

Monoclonal Antibody and Cytokine Therapeutics

Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.

Tags: autoimmune diseases, biopharmaceutical, cancer treatment, cytokines, monoclonal antibodies

Symbol: XNCR

Recent Price: $23.71

Industry: Biotechnology

CEO: Dr. Bassil I. Dahiyat Ph.D.

Sector: Healthcare

Employees: 280

Address: 111 West Lemon Avenue, Monrovia, CA 91016

Phone: 626 305 5900

Last updated: 2024-12-31

Penumbra, Inc.

Penumbra, Inc. logo
Market Cap: Highest
Employees: High

Penumbra System

Penumbra, Inc. designs, develops, manufactures, and markets medical devices, including aspiration-based thrombectomy systems, accessory devices, neurovascular embolization coiling systems, and neurosurgical aspiration tools, serving the United States and international markets.

Tags: Embolization, Medical Devices, Neurosurgical Tools, Neurovascular, Thrombectomy Systems

Symbol: PEN

Recent Price: $238.18

Industry: Medical - Devices

CEO: Mr. Adam Elsesser

Sector: Healthcare

Employees: 4200

Address: One Penumbra Place, Alameda, CA 94502

Phone: 510 748 3200

Last updated: 2024-12-31

Arcus Biosciences, Inc.

Arcus Biosciences, Inc. logo
Market Cap: High
Employees: Medium

Cancer Therapies

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.

Tags: biopharmaceutical, cancer therapies, clinical trials, oncology

Symbol: RCUS

Recent Price: $14.91

Industry: Biotechnology

CEO: Dr. Terry J. Rosen Ph.D.

Sector: Healthcare

Employees: 577

Address: 3928 Point Eden Way, Hayward, CA 94545

Phone: 510 694 6200

Last updated: 2024-12-31

Haemonetics Corporation

Haemonetics Corporation logo
Market Cap: High
Employees: High

Nex Sys PCS, PCS2, Nex Lynk DMS, MCS brand apheresis equipment, Safe Trace Tx, Blood Track

Haemonetics Corporation is a healthcare company providing medical products and solutions across Plasma, Blood Center, and Hospital segments. They offer automated plasma collection devices, related disposables, software, and donor management systems.

Tags: apheresis equipment, blood components, blood management, donor management, healthcare, medical products, plasma collection

Symbol: HAE

Recent Price: $76.60

Industry: Medical - Instruments & Supplies

CEO: Mr. Christopher A. Simon

Sector: Healthcare

Employees: 3657

Address: 125 Summer Street, Boston, MA 02110

Phone: 781 848 7100

Last updated: 2024-12-31